Allow pharmacist-supervised over-the-counter access to asthma reliever inhalers

In the UK, short-acting asthma reliever inhalers are prescription-only, patients must obtain a GP appointment for each supply. This can be dangerous for those with breathlessness or who run out unexpectedly. Evidence from the MHRA, NICE, and Asthma + Lung UK shows that short-acting agonists such as salbutamol are safe and effective when used as directed. Reclassification to (P) status would allow supply under pharmacist supervision, with safeguards red-flag screening and referral to a GP.